Shangqiu First People's Hospital
In research, Shangqiu First People's Hospital stands highest in Medicine (#8,574 of 10,443 worldwide) and Health Sciences (#10,280 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #16,712 of 28,054 · #22,444 all time
- Rank in China
- #2,597 of 3,058
- Research works
- 1.8k ▼ 56% vs 2013–17
- Citations
- 5.6k 3.1 per fractional work
- Top-10% rate
- 14.3% record average 16.5%
- Open access
- 11% world 28%
What is Shangqiu First People's Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #8,574 of 10,443 | 14.5% | 64 | #10422 | |
| Health SciencesDomain | #10,280 of 11,982 | 14.7% | 66 | #13080 |
Each strip is that field’s whole ranked pool, with the notch where Shangqiu First People's Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.2×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 5.2×
- Immunology and Microbiology 4.1×
- Biochemistry, Genetics and Molecular Biology 3.3×
- Neuroscience 3.3×
- Medicine 3.0×
- Chemistry 1.1×
- Health Professions 0.6×
- Chemical Engineering 0.4×
- Agricultural and Biological Sciences 0.3×
- Environmental Science 0.3×
- Psychology 0.3×
- Materials Science 0.3×
- Decision Sciences 0.2×
- Engineering 0.2×
- Earth and Planetary Sciences 0.1×
- Computer Science 0.1×
- Physics and Astronomy 0.1×
- Social Sciences 0.0×
- Economics, Econometrics and Finance 0.0×
Which keywords describe research at Shangqiu First People's Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Epidemiology, Biomarkers, Oxidative Stress, Clinical Practice Guidelines, Metastasis and Biogenesis.
- Preoperative Chemoradiotherapy
- Therapeutics
- Endoscopic Resection
- Macrophages
- Circular RNAs
- MicroRNA
- Neoadjuvant Therapy
- Mortality
- Cytokines
- Cancer Biomarkers
- Guidelines
- RNA Regulation
- Diagnosis
- Chemotherapy
- Epigenetic Regulation
- Regulation
- Metastasis
- Cardiovascular Disease
- Oxidative Stress
- Cancer
- Epidemiology
- Inflammation
- Biomarkers
- Clinical Practice Guidelines
- Treatment
- Biogenesis
- Gene Expression
- Tumor Microenvironment
- Long Noncoding RNAs
- Management
- Immune Response
- Global Burden
- Immunity
- Critical Care
- Sepsis
- Cellular Functions
- Ischemic Stroke
- MicroRNA Sponges
- Targeting
- Chemoradiation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology12▲ 2.8×42 topics
- Cancer12▲ 8.2×27 topics
- Inflammation10▲ 4.6×37 topics
- Oxidative Stress6▲ 3.6×18 topics
- Biomarkers6▲ 8.0×13 topics
- Cardiovascular Disease5▲ 4.4×17 topics
- Clinical Practice Guidelines4▲ 7.6×12 topics
- Metastasis4▲ 12×7 topics
- Treatment4▲ 3.3×17 topics
- Regulation4▲ 7.2×6 topics
- Biogenesis4▲ 21×3 topics
- Epigenetic Regulation4▲ 17×4 topics
- Gene Expression4▲ 6.0×8 topics
- Chemotherapy4▲ 5.1×16 topics
- Tumor Microenvironment4▲ 7.7×7 topics
- Diagnosis3▲ 2.9×11 topics
- Long Noncoding RNAs3▲ 32×1 topic
- RNA Regulation3▲ 26×1 topic
- Management3▲ 3.3×8 topics
- Guidelines3▲ 5.5×6 topics
- Immune Response3▲ 4.5×13 topics
- Cancer Biomarkers3▲ 29×3 topics
- Global Burden3▲ 4.7×9 topics
- Cytokines3▲ 8.3×7 topics
- Immunity2▲ 5.7×5 topics
- Mortality2▲ 4.0×8 topics
- Critical Care2▲ 8.9×4 topics
- Neoadjuvant Therapy2▲ 8.9×5 topics
- Sepsis2▲ 12×5 topics
- MicroRNA2▲ 16×2 topics
- Cellular Functions2▲ 24×2 topics
- Circular RNAs2▲ 45×1 topic
- Ischemic Stroke2▲ 12×3 topics
- Macrophages2▲ 10×6 topics
- MicroRNA Sponges2▲ 45×1 topic
- Endoscopic Resection2▲ 17×2 topics
- Targeting2▲ 23×1 topic
- Therapeutics2▲ 16×1 topic
- Chemoradiation2▲ 24×2 topics
- Preoperative Chemoradiotherapy2▲ 19×2 topics
Which research topics does Shangqiu First People's Hospital publish most on?
By volume in 2022–2025: Cancer-related molecular mechanisms research, Circular RNAs in diseases, MicroRNA in disease regulation and Ferroptosis and cancer prognosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer-related molecular mechanisms research Cancer Research 3 works
- 2 Circular RNAs in diseases Molecular Biology 2 works
- 3 MicroRNA in disease regulation Cancer Research 2 works
- 4 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 1 works
- 5 Esophageal Cancer Research and Treatment Surgery 1 works
- 6 Neurological Disease Mechanisms and Treatments Neurology 1 works
- 7 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 8 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 1 works
- 9 Wound Healing and Treatments Rehabilitation 1 works
- 10 Sepsis Diagnosis and Treatment Epidemiology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Shangqiu First People's Hospital's research output changed?
Output in 2018–2022 was 56% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Shangqiu
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.